MEDICAL THERAPY OF PULMONARY HYPERTENSION: The Prostacyclins
- 1 September 2001
- journal article
- review article
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 22 (3) , 529-537
- https://doi.org/10.1016/s0272-5231(05)70289-6
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary HypertensionNew England Journal of Medicine, 1998
- Pulmonary Hypertension -- Beyond Vasodilator TherapyNew England Journal of Medicine, 1998
- Short-term hemodynamic effect of a new oral PGI2 analogue, Beraprost, in primary and secondary pulmonary hypertensionThe American Journal of Cardiology, 1996
- Positive inotropic and chronotropic effects of beraprost sodium, a stable analogue of prostacyclin, in isolated guinea pig myocardiumGeneral Pharmacology: The Vascular System, 1996
- Role of prostacyclin in the treatment of primary pulmonary hypertensionThe American Journal of Cardiology, 1995
- Pharmacodynamic profile of prostacyclinThe American Journal of Cardiology, 1995
- Role of pharmacologic tests in the treatment of primary pulmonary hypertensionThe American Journal of Cardiology, 1995
- Acute hemodynamic effects of the prostacyclin analog 15AU81 in severe congestive heart failureThe American Journal of Cardiology, 1995
- Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.Circulation, 1982
- Zur Kenntnis der pharmakologischen Wirkungen von Nativsekreten und Extrakten männlicher accessorischer GeschlechtsdrüsenNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1934